Latest update:
Friday, September 29, 2023 - 14:01
Sofia, Bulgaria, 29 September 2023 – According to the requirements of Art. 100t of the LPOS and in connection with Art. 114, para. 9 of the LPOS, "Sopharma" AD informs that, after a request made to the parent company, public company "Sopharma" AD by the subsidiary "Pharmalogistika" AD and consent given by the Board of Directors from 12.09.2023, today the subsidiary concluded the following transaction falling within the scope of Art. 114, para. 3 of the LPOS:
A) Stakeholder participation:
- Boris Anchev Borisov, who is a member of the Board of Directors of "Pharmalogistika" AD, and at the same time is a Procurator of "Sopharma Trading" AD - grounds for interest under Art. 114, para. 7, item 3 of the LPOS.
B) Value of the transaction:
The market price of the leased property is determined according to a market valuation prepared by an independent appraiser under Art. 5 of The Law of Independents Appraisers.
C) Assessment of the applicability of the conditions under Art. 114, para. 3, item 1 of the LPOS: The value of the described transaction exceeds the threshold under Art. 114, para. 3, item 1 b. b) of LPOS, which is why prior approval by the parent company, a public company, is required.
D) Assessment of the applicability of Art. 114 para. 6 of the LPOS:
|
|
Value of the assets provided for use, under the considered transaction with „Sopharma Trading“ AD under the current request in BGN |
BGN 88,801 |
Value of the assets provided for use, according to a previously concluded transaction with the same legal person under, subject to cumulation under Art. 114, para. 6 of the LPOS |
BGN 88,137 |
Total value with cumulation under Art. 114, para. 6 of the LPOS of the assets provided for use |
BGN 176,938 |
Threshold under Art. 114, para. 3, item 1, b. "b" |
BGN 107,950 |